Zai Lab

ZAI’s stock rose 2.9% to HK$1,230 after the company reported revenue of RMB 954m, an increase of almost 400% year on year. The half-year loss narrowed, indicating margin improvement. Inclusion in the MSCI China Index triggers expected purchases by passive funds and broadens the institutional investor base, causing the stock to show strength against the falling Hang Seng. » Mais em de.investing.com

ZAI shares climbed 8.4% on Wednesday to HK$1,095 after Bernstein initiated coverage with an “Outperform” and a HK$1,350 price target. The move followed a short-lived leak and withdrawal of documentation for the successor model GLM-5.3, which had already sparked a rally. Additional speculation about a potential flagship GLM-5.5, which JPMorgan expects to be released in August 2026, boosted investor sentiment; rival MiniMax, by contrast, received only a “Market Perform.” » Mais em de.investing.com

The European Medicines Agency granted orphan drug designation to zocilurtatug pelitecan (zoci), Zai Lab’s DLL3‑targeting antibody‑drug conjugate for pulmonary neuroendocrine carcinomas. The decision, backed by the EMA committee’s positive recommendation, reflects unmet need and early clinical data showing durable responses in relapsed or refractory extensive‑stage small cell lung cancer. The designation may bring development incentives and potential market exclusivity for Zai Lab. » Mais em finance.yahoo.com

Zai Lab shareholders voted in favor of all resolutions presented at the 2026 annual general meeting, including the re-election of several directors to serve until 2027 and the appointment of KPMG as independent auditors for the 2026 fiscal year. An advisory resolution on board compensation was approved. Shareholders also granted two general authorizations: one to issue or resell up to 10% of the issued ordinary shares/ADS and one to repurchase up to 10% of the issued ordinary shares/ADS until the 2027 annual general meeting. » Mais em de.investing.com

Zai Lab said Josh Smiley will resign as president and chief operating officer effective Monday; his last day is next Thursday. Smiley’s duties will be taken over by founder and CEO Samantha Du and other members of the leadership team. Smiley will receive a contractually agreed severance if he signs a customary release; the information comes from an 8‑K filing with the SEC. » Mais em de.investing.com